Eye injection shows promise in preventing repeat retinal detachment
NCT ID NCT06425419
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This early-stage study tests whether an injection of the drug topotecan into the eye can safely prevent retinal detachment from coming back in people with a condition called proliferative vitreoretinopathy (PVR). About 50 adults having retinal detachment surgery will either receive the injection or standard care alone. Researchers will track side effects and check if the retina stays attached for 6 months after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLIFERATIVE VITREO-RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye scans aim to predict Sight-Threatening complication after retinal surgery
- Could a single injection replace weeks of eye drops after retinal surgery?
- Eye surgery showdown: one step or two for retinal detachment?
- Silicone Oil's hidden impact on retinal signals revealed in new study
- Eye surgery silicone may change cornea cells, study finds
- Can eye scans and fluid predict who will develop a complication after retinal detachment repair?